» Articles » PMID: 24682267

The Genomic Landscape of Mantle Cell Lymphoma is Related to the Epigenetically Determined Chromatin State of Normal B Cells

Abstract

In this study, we define the genetic landscape of mantle cell lymphoma (MCL) through exome sequencing of 56 cases of MCL. We identified recurrent mutations in ATM, CCND1, MLL2, and TP53. We further identified a number of novel genes recurrently mutated in patients with MCL including RB1, WHSC1, POT1, and SMARCA4. We noted that MCLs have a distinct mutational profile compared with lymphomas from other B-cell stages. The ENCODE project has defined the chromatin structure of many cell types. However, a similar characterization of primary human mature B cells has been lacking. We defined, for the first time, the chromatin structure of primary human naïve, germinal center, and memory B cells through chromatin immunoprecipitation and sequencing for H3K4me1, H3K4me3, H3Ac, H3K36me3, H3K27me3, and PolII. We found that somatic mutations that occur more frequently in either MCLs or Burkitt lymphomas were associated with open chromatin in their respective B cells of origin, naïve B cells, and germinal center B cells. Our work thus elucidates the landscape of gene-coding mutations in MCL and the critical interplay between epigenetic alterations associated with B-cell differentiation and the acquisition of somatic mutations in cancer.

Citing Articles

Circulating tumor DNA in lymphoma: technologies and applications.

Fu L, Zhou X, Zhang X, Li X, Zhang F, Gu H J Hematol Oncol. 2025; 18(1):29.

PMID: 40069858 PMC: 11900646. DOI: 10.1186/s13045-025-01673-7.


Biological and clinical determinants shaping heterogeneity in mantle cell lymphoma.

Lopez C, Silkenstedt E, Dreyling M, Bea S Blood Adv. 2024; 8(14):3652-3664.

PMID: 38748869 PMC: 11284685. DOI: 10.1182/bloodadvances.2023011763.


Case report: Mutation evolution in a patient with TdT positive high grade B cell lymphoma with MYC and BCL2 rearrangements following the treatment of concurrent follicular lymphoma and diffuse large B-cell lymphoma.

Zhang F, Chen Y, Cui Q, Ge Y, Liu Y Discov Oncol. 2024; 15(1):129.

PMID: 38662249 PMC: 11045710. DOI: 10.1007/s12672-024-00991-5.


Targeting DNMT3A-mediated oxidative phosphorylation to overcome ibrutinib resistance in mantle cell lymphoma.

Hoang N, Liu Y, Bates P, Heaton A, Lopez A, Liu P Cell Rep Med. 2024; 5(4):101484.

PMID: 38554704 PMC: 11031386. DOI: 10.1016/j.xcrm.2024.101484.


Drug Discovery Targeting Nuclear Receptor Binding SET Domain Protein 2 (NSD2).

Ma Z, Bolinger A, Chen H, Zhou J J Med Chem. 2023; 66(16):10991-11026.

PMID: 37578463 PMC: 11092389. DOI: 10.1021/acs.jmedchem.3c00948.


References
1.
Langmead B, Trapnell C, Pop M, Salzberg S . Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol. 2009; 10(3):R25. PMC: 2690996. DOI: 10.1186/gb-2009-10-3-r25. View

2.
Bea S, Valdes-Mas R, Navarro A, Salaverria I, Martin-Garcia D, Jares P . Landscape of somatic mutations and clonal evolution in mantle cell lymphoma. Proc Natl Acad Sci U S A. 2013; 110(45):18250-5. PMC: 3831489. DOI: 10.1073/pnas.1314608110. View

3.
Cock P, Fields C, Goto N, Heuer M, Rice P . The Sanger FASTQ file format for sequences with quality scores, and the Solexa/Illumina FASTQ variants. Nucleic Acids Res. 2009; 38(6):1767-71. PMC: 2847217. DOI: 10.1093/nar/gkp1137. View

4.
Love C, Sun Z, Jima D, Li G, Zhang J, Miles R . The genetic landscape of mutations in Burkitt lymphoma. Nat Genet. 2012; 44(12):1321-5. PMC: 3674561. DOI: 10.1038/ng.2468. View

5.
Kridel R, Meissner B, Rogic S, Boyle M, Telenius A, Woolcock B . Whole transcriptome sequencing reveals recurrent NOTCH1 mutations in mantle cell lymphoma. Blood. 2012; 119(9):1963-71. DOI: 10.1182/blood-2011-11-391474. View